Ingenol derivatives are highly potent and selective inhibitors of HIV replication in vitro

Antiviral Chemistry and Chemotherapy

Volumn 7, Issue 5, 1996, Pages 230-236

  Fujiwara, M ^a   Ijichi, K ^a   Tokuhisa, K ^b   Katsuura, K ^b   Wang, G Y S ^c   Uemura, D ^c,d   Shigeta, S ^e   Konno, K ^a   Yokota, T ^a   Baba, M ^f  

^a Rational Drug Design Laboratories   (Japan)

^b TOSOH CORPORATION   (Japan)

^c SHIZUOKA UNIVERSITY   (Japan)

^d SAGAMI CHEMICAL RESEARCH CENTER   (Japan)

^e FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^f KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Anti HIV activity; Ingenol; Protein kinase C

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; AURINTRICARBOXYLIC ACID; CD4 ANTIGEN; INGENOL; INGENOL DERIVATIVE; MEMBRANE ANTIGEN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; RD 3 2448; RD 4 2053; RD 4 2055; RD 4 2118; RD 4 2138; RD 4 2174; RD 4 2176; RD 4 2227; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; PRIORITY JOURNAL; SYNCYTIUM; T LYMPHOCYTE; VIRUS ADSORPTION; VIRUS REPLICATION; VIRUS STRAIN;

EID: 9544248640     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029600700502     Document Type: Article

References (23)

1. Abrams, D.I., Kuno, S., Wong, R., Jeffords, K., Nash, M., Molaghan, J.B., Gorther, R., and Ueno, R. (1989) Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Ann Intern Med 110: 183-188.
2. Baba, M., Schols, D., Pauwels, R., Balzarini, J., and De Clercq, E. (1988a) Fuchsin acid selectively inhibits human immunodeficiency virus (HIV) replication in vitro. Biochem Biophys Res Commun 155: 1404-1411.
3. Baba, M., Pauwels, R., Balzarini, J., Arnout, J., Desmyter, J., and De Clercq, E. (1988b) Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc Natl Acad Sci USA 85: 6132-6136.
4. Baba, M., Schols, D., Pauwels, R., Nakashima, H., and De Clercq, E. (1990) Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy. J AIDS 3: 493-499.
5. Baba, M., De Clercq, E., Tanaka, H., Ubasawa, M., Takashima, H., Sekiya, K., Nitta, I., Umezu, K., Nakashima, H., Mori, S., Shigeta, S., Walker, R.T., and Miyasaka, T. (1991) Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase. Proc Natl Acad Sci USA 88: 2356-2360.
6. Baba, M., Shigeta, S., Yuasa, S., Takashima, H., Sekiya, K., Ubasawa, M., Tanaka, H., Miyasaka, T., Walker, R.T., and De Clercq, E. (1994) Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro. Antimicrob Agents Chemother 38: 688-692.
7. Balzarini, J., Mitsuya, H., De Clercq, E., and Broder, S. (1986) Aurintricarboxylic acid and evans blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. Biochem Biophys Res Commun 136: 64-71.
8. Chowdhury, M.I.H., Koyanagi, Y., Kobayashi, S., Hamamoto, Y., Yoshiyama, H., Yoshida, T., and Yamamoto, N. (1990) The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: possible involvement of protein kinase C pathway. Virology 176: 126-132.
9. Dalgleish, A.G., Beverley, P.C.L., Clapham, P.R., Crawford, D.H., Greaves, M.F., and Weiss, R.A. (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763-767.
10. Fujiwara, M., Ijichi, K., Tokuhisa, K., Katsuura, K., Shigeta, S., Konno, K., Wang, G.-Y.-S., Uemura, D., Yokota, T., and Baba, M. (1996) Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate. Antimicrob Agents Chemother 40: 271-273.
11. Golding, H., Manischewitz, J., Vujcic, L., Blumenthal, R., and Dimitrov, D.S. (1994) The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells. J Virol 68: 1962-69.
12. Harada, S., Koyanagi, Y., and Yamamoto, N. (1985) Infection of HTLV-III/LAV in HTLV-1-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229: 563-566.
13. Haslar, C.M., Acs, G., and Blumberg, P.M. (1992) Specific binding to protein kinase C by ingenol and its induction of biological responses. Cancer Res 52: 202-208.
14. Kikkawa, U., Takai, Y., Minakuchi, R., Inohara, S., and Nishizuka, Y. (1982) Calcium-activated, phospholipiddependent protein kinase from rat brain. J Biol Chem 257: 13341-13348.
15. Kikukawa, R., Koyanagi, Y., Harada, S., Kobayashi, N., Hatanaka, M., and Yamamoto, N. (1986) Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. J Virol 57: 1159-1162.
16. Klatzman, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.-C., and Montagnier, L. (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312: 767-768.
17. Larder, B.A., Darby, G., and Richman, D.D. (1989) HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243: 1731-1734.
18. + T cells by a complex of the 110K viral protein and the T4 molecule. Science 231: 382-385.
19. Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter, J., and De Clercq, E. (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods 20: 309-321.
20. Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M.J., Breslin, H.J., Raeymaeckers, A., Gelder, J.V., Woestenborghs, R., Heykants, J., Scheilekens, K., Janssen, M.A.C., De Clercq, E., and Janssen, P.A.J. (1990) Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature 343: 470-474.
21. Schols, D., Baba, M., Pauwels, R., Desmyter, J., and De Clercq, E. (1989) Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. Proc Natl Acad Sci USA 86: 3322-3326.
22. Seki, M., Sadakata, Y., Yuasa, S., and Baba, M. (1995) Isolation and characterization of human immunodeficiency virus type-1 mutants resistant to the non-nucleoside reverse transcriptase inhibitor MKC-442. Antiviral Chem Chemother 6: 73-79.
23. Witvrouw, M., Este, J.A., Mateu, M.Q., Reyman, D., Andrei, G., Snoeck, R., Ikeda, S., Pauwels, R., Bianchini, N.V., Desmyter, J., and De Clercq, E. (1994). Activity of a sulfated polysaccharide extracted from the red seaweed Aghardhiella tenera against human immunodeficiency virus and other enveloped viruses. Antiviral Chem Chemother 5: 297-303.